PIN31 DOLUTEGRAVIR PLUS LAMIVUDINE FOR THE TREATMENT OF ART NAIVE ADULTS LIVING WITH HUMAN IMMUNODEFICIENCY VIRUS (HIV): A US COST-UTILITY ANALYSIS
May 1, 2019, 00:00
10.1016/j.jval.2019.04.902
https://www.valueinhealthjournal.com/article/S1098-3015(19)31094-0/fulltext
Title :
PIN31 DOLUTEGRAVIR PLUS LAMIVUDINE FOR THE TREATMENT OF ART NAIVE ADULTS LIVING WITH HUMAN IMMUNODEFICIENCY VIRUS (HIV): A US COST-UTILITY ANALYSIS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)31094-0&doi=10.1016/j.jval.2019.04.902
First page :
Section Title :
Open access? :
No
Section Order :
10460